FIELD: medicine.
SUBSTANCE: when treating chronic virus hepatitis a patient is intramuscularly injected with human alpha-interferon and alpha-fetoprotein mixed in the injector immediately prior to use. The said mixture is injected once a day within 30 days.
EFFECT: accelerated virus eradication in case of high therapy tolerability and absence of IFN treatment side effects.
3 ex
Title | Year | Author | Number |
---|---|---|---|
MEDICATION COMPOSITION AND METHOD OF ITS OBTAINING FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B OR C AND AIDS | 2010 |
|
RU2440133C2 |
CYTOKINE-CONTAINING COMPOSITION FOR TREATING VIRAL DISEASES | 2009 |
|
RU2447897C2 |
METHOD OF TREATING VIRAL HEPATITES | 2012 |
|
RU2489154C1 |
METHOD OF TREATING CHRONIC VIRAL HEPATITIS C WITH MEDICATIONS IN LIPOSOMAL FORM | 2011 |
|
RU2475263C1 |
METHOD FOR TREATING CHRONIC VIRAL HEPATITIS | 2004 |
|
RU2265447C1 |
METHOD FOR PREDICTING THE RESULTS OF TREATING PATIENTS WITH CHRONIC HEPATITIS C WITH INTERFERON-ALPHA PREPARATIONS | 2005 |
|
RU2287825C1 |
METHOD FOR PREDICTING EFFICIENCY OF INTERFERONOTHERAPY AT CHRONIC HEPATITIS B | 2005 |
|
RU2287826C1 |
METHOD OF PREVENTING VERTICAL TRANSMISSION OF HEPATITIS B AND C VIRUSES IN PREGNANT WOMEN WITH REACTIVATION OF VIRUSES IN THIRD TRIMESTER | 2011 |
|
RU2473341C1 |
METHOD OF TREATING CHRONIC VIRAL HEPATITIS C | 2011 |
|
RU2459629C1 |
METHOD OF TREATING CONDITIONS CHARACTERIZING BY AUTOIMMUNE AGGRESSION | 1995 |
|
RU2137477C1 |
Authors
Dates
2009-10-10—Published
2008-05-22—Filed